Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Carboplatin in Metastatic or Recurrent Head and Neck Cancer
NCT00003908Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Nov 1999
- Primary completion
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by SWOG Cancer Research Network. Started Nov 1999; status: completed.
02
Drugs
docetaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00003908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003908.